Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2009
10/22/2009US20090264521 Percutaneous absorption preparation
10/22/2009US20090264497 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
10/22/2009US20090264467 Agents and crystals for improving excretory potency of urinary bladder
10/22/2009US20090264414 Amide Derivatives and Pharmaceutical Use Thereof
10/22/2009US20090264413 Compositions and Methods for Treating Female Sexual Dysfunction
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090263916 Antagonists of HMG1 for treating inflammatory conditions
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263784 Three-dimensional structure of prostaglandin d synthase and utilization thereof
10/22/2009US20090263488 Pressurised metered dose inhalers containing solutions of beta-2 agonists
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263421 Cellular vaccine
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263389 Use of TGF-Beta Antagonists to Treat or to Prevent Chronic Transplant Rejection
10/22/2009US20090263362 Fertility enhancement using lipid carriers and bioactive molecules
10/22/2009US20090263358 autologously transplanting hematopoietic progenitor cell population which has been treated with antibody (monoclonal, chimeric, or humanized; not conjugated to toxin or cytolytic agent); radiotherapy
10/22/2009US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/22/2009US20090261014 Dispenser For Progestin Used For Acute Maintenance Treatment Of DUB
10/22/2009CA2721749A1 Combination therapy for glaucoma
10/22/2009CA2721457A1 Topical combinations comprising an antimycotic agent and an antiviral agent
10/21/2009EP2110434A1 Type-1 cytokine receptor GLM-R
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2110141A1 Protective agent for retinal nerve or optic nerve
10/21/2009EP2109462A1 Antitumor combination comprising a morpholinyl anthracycline and an antibody
10/21/2009EP2109461A2 Method for improving pharmacokinetics
10/21/2009EP2109452A1 Use of a leukocyte diminishing or inactivating agent in combination with bacterially-mediated tumor treatment
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1392359B1 Specific binding proteins and uses thereof
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009EP1207877B1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids
10/21/2009EP1162968B1 Epigallocatechin-gallate for inhibiting angiogenesis
10/21/2009EP1047436B1 N-acetylhomotaurinates for use in treating hyperkinesias
10/21/2009EP0986372B1 Vesicular complexes and methods of making and using the same
10/21/2009CN101563134A Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
10/21/2009CN101563106A Combination of nmda- receptor ligand and a compound with 5-HT6 receptor affinity
10/21/2009CN101563091A Composition comprising crustacean gastrolith components and its use
10/21/2009CN101563083A Combinations containing a 4-acylaminopyridine derivative
10/21/2009CN101563074A Acetaminophen / ibuprofen combinations
10/21/2009CN101560521A VA1-missing adenovirus vector for expressing small interfering RNA (siRNA) and constructing method and application thereof
10/21/2009CN101559228A Pharmaceutical composition for treating chronic stable angina pectoris with hyperlipemia
10/21/2009CN101559227A Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions
10/21/2009CN100551464C Five-element magnetotherapeutic health caring belt
10/21/2009CN100551458C An aerosol forming device for use in inhalation therapy
10/21/2009CN100551443C Nano carbon tube infusion agent preparation method
10/21/2009CN100551442C Medicinal composition containing calcium passage paralysor and B family vitamin and its use
10/21/2009CN100551370C Use of Ranolazine in preparing pharmaceutical composition for treating diabetes
10/21/2009CA2629547A1 Compositions of phosphodiesterase type iv inhibitors
10/20/2009US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia
10/20/2009US7605233 Tumour necrosis factor binding ligands
10/20/2009US7605152 such as 16 alpha -fluoro-17 beta -hydroxy-4-methyl-4-aza-5 alpha -androst-1-en-3-one, used for hormone replacement therapy
10/20/2009US7605138 Nucleic acid compositions for stimulating immune responses
10/20/2009US7605133 Isolated peptides to treat alpha-synuclein diseases
10/20/2009US7604949 For skin lightening or darkening; cell-free; drug screening
10/20/2009US7604818 Biocompatible fluoropolymers useful for coating implantable devices such as stents; mechanical strength; flexibility;elongation; drug delivery devices; release agents; restenosis prevention; permeability; reservoirs;isobutylene-vinylidene fluoride copolymer; styrene-vinylidene fluoride copolymer
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2469821C Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
10/20/2009CA2450122C Novel heterocyclic antibacterial compounds
10/20/2009CA2402267C Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails
10/20/2009CA2378428C Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
10/20/2009CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/15/2009WO2009126931A2 Combination therapy for bipolar disorder
10/15/2009WO2009126917A1 Method of providing hemostasis in anti-coagulated blood
10/15/2009WO2009126682A2 Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
10/15/2009WO2009125804A1 Screening method
10/15/2009WO2009125798A1 Method for screening of pharmaceutical candidate substance for treatment of cancer in which hedgehog pathway is activated
10/15/2009WO2009125607A1 Apoptosis inducer
10/15/2009WO2009124702A1 Contraceptive estra-1,3,5(10)-triene derivatives
10/15/2009WO2009124552A2 Use of a combination of hypothermia inducing drugs
10/15/2009WO2009124396A1 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity
10/15/2009WO2009099563A3 Combination of a nmda receptor channel blocker and a pkc activator for treatment of alzheimer's disease
10/15/2009WO2009090210A3 Combination of metformin and an mtp inhibitor
10/15/2009WO2009052454A3 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss
10/15/2009WO2009050372A3 Compositions containing lipophosphoramides and use thereof in gene therapy
10/15/2009WO2009023943A8 Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090258919 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure
10/15/2009US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009US20090258844 Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258409 Purified sr-p70 protein
10/15/2009US20090258089 Chemo- and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides
10/15/2009US20090258046 Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
10/15/2009US20090258033 HCV E1E2 vaccine compositions
10/15/2009US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides
10/15/2009US20090257994 Chimeric immunoreceptor useful in treating human cancers
10/15/2009US20090257989 Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells
10/15/2009US20090257987 Method of generating dopamine-secreting cells
10/15/2009US20090257986 Epidermal and dermal equivalents
10/15/2009US20090257984 Antifungal compositions containing the endophyte fungus alternaria alternata and or its metabolites, as antagonist agents of plasmopara viticola
10/15/2009DE102008018304A1 Topical product, useful e.g. to prevent skin wrinkling caused by e.g. thrombophilia, comprises branched amino acids, N-hydroxy-L-arginine, boric acid derivative, chloroquine as arginase inhibitor and/or complex agent for manganese ion
10/15/2009DE102008011800A1 Orally disintegrating film, useful e.g. to combat parasites in animals, preferably fish, exotic or wild animals, comprises a matrix made of a polymer of modified pea starch and an antiparasitic agent e.g. ivermectin and selamectin
10/15/2009CA2740950A1 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity
10/14/2009EP2108404A1 Anti-bacterial extracts from mammea americana and marchantia polymorpha
10/14/2009EP2108378A2 Non-covalent bioconjugates useful for diagnosis and therapy
10/14/2009EP2108377A1 Vascularization inhibitors
10/14/2009EP2108373A1 Treatment of tumor metastases
10/14/2009EP2108371A1 Estra-1,3,5(10)-trie derivatives for contraception
10/14/2009EP2108359A1 Warming and nonirritating lubricant compositions
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 1151